Alexander Cumbo - 31 Jan 2025 Form 4 Insider Report for Solid Biosciences Inc. (SLDB)

Role
President and CEO, Director
Signature
/s/ Kimberly Cornwell as attorney-in-fact for Alexander Cumbo
Issuer symbol
SLDB
Transactions as of
31 Jan 2025
Net transactions value
$0
Form type
4
Filing time
11 Feb 2025, 16:38:08 UTC
Previous filing
04 Dec 2024
Next filing
18 Feb 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding SLDB Common Stock 42,051 31 Jan 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SLDB Restricted Stock Units Award $0 +401,600 $0.000000 401,600 31 Jan 2025 Common Stock 401,600 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 3,567 shares of the issuer's common stock acquired under the Solid Biosciences Inc. Employee Stock Purchase Plan on November 29, 2024.
F2 Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock (the "RSUs").
F3 The RSUs were granted on the January 31, 2025 (the "Grant Date") and vest over four years, with 25% of the original number of shares vesting on each anniversary of the Grant Date until the fourth such anniversary.

Remarks:

Exhibit Index: 24.1 Power of Attorney